Table 3. The BD/TDD ratio and insulin dose per kilogram of body weight were then analyzed by stratifying the study subject with age, DM duration, BMI, HbA1c, C peptide level, fasting and 2h glucose level on admission and discharged from hospital, and usage of metformin.
Variables | BD/TDD ratio | insulin doses perkilogram of body weight | Total insulin doseper day | |
Age* | ≤53 years | 0.24±0.09 | 0.57±0.21 | 38.96±14.25 |
54–66 years | 0.23±0.08 | 0.59±0.23 | 39.75±16.14 | |
≥67 years | 0.21±0.08 | 0.57±0.22 | 35.90±14.04 | |
DM duration | ≤7years | 0.22±0.08 | 0.53±0.21 | 35.60±13.63 |
8–14years | 0.23±0.09 | 0.58±0.22 | 38.87±14.80 | |
≥15years | 0.23±0.09 | 0.62±0.23 | 40.30±15.88 | |
BMI* | <22.2 kg/m2 | 0.21±0.09 | 0.63±0.23 | 34.41±12.33 |
22.2–25.8 kg/m2 | 0.22±0.08 | 0.56±0.21 | 36.89±13.66 | |
≥25.9 kg/m2 | 0.24±0.09 | 0.56±0.22 | 43.40±16.99 | |
HbA1c | ≤8.2% | 0.22±0.09 | 0.52±0.20 | 34.65±13.99 |
8.3–10.1% | 0.23±0.08 | 0.60±0.24 | 40.66±16.14 | |
≥10.2% | 0.24±0.08 | 0.62±0.21 | 39.98±13.61 | |
fasting C-peptide | <1.18 ng/dl | 0.23±0.08 | 0.59±0.21 | 37.42±12.54 |
1.18–2.04 ng/dl | 0.23±0.08 | 0.59±0.21 | 40.32±15.23 | |
≥2.05 ng/dl | 0.22±0.08 | 0.58±0.23 | 40.98±16.30 | |
Postprandial C-peptide | <1.89 ng/dl | 0.24±0.08 | 0.62±0.21 | 38.42±12.91 |
1.89–3.48 | 0.24±0.08 | 0.61±0.22 | 41.84±15.13 | |
≥3.49 | 0.22±0.07 | 0.55±0.22 | 38.87±15.84 | |
FBG (mmol/L) when admission * | <6.95 | 0.21±0.08 | 0.53±0.20 | 35.26±14.07 |
6.95–9.39 | 0.23±0.08 | 0.59±0.22 | 39.39±14.41 | |
≥9.4 | 0.25±0.08 | 0.64±0.23 | 42.66±15.15 | |
2 hrPBG (mmol/L) when admission * | <11.1 | 0.22±0.09 | 0.54±0.20 | 35.98±13.69 |
11.1–15 | 0.23±0.09 | 0.59±0.23 | 39.97±16.10 | |
≥15.1 | 0.24±0.08 | 0.63±0.22 | 41.34±14.43 | |
FBG (mmol/L) Discharged from hospital | <6.4 | 0.22±0.08 | 0.55±0.21 | 36.12±13.18 |
6.4–7.5 | 0.22±0.08 | 0.51±0.21 | 38.51±14.32 | |
≥7.6 | 0.24±0.09 | 0.62±0.24 | 40.55±16.53 | |
2 hrPBG (mmol/L) Discharged from hospital * | <7.8 | 0.24±0.08 | 0.58±0.22 | 37.80±14.03 |
7.8–9.2 | 0.22±0.08 | 0.57±0.22 | 38.11±14.02 | |
≥9.3 | 0.21±0.08 | 0.59±0.23 | 39.43±15.78 | |
Usage of metformin* | Insulin alone | 0.22±0.09 | 0.57±0.23 | 35.44±14.27 |
Insulin+metformin | 0.24±0.08 | 0.59±0.22 | 40.51±15.06 | |
Creatinine (umol/L) | <66 | 0.24±0.08 | 0.61±0.22 | 40.13±15.32 |
66–83 | 0.23±0.08 | 0.58±0.22 | 38.58±14.63 | |
≥84 | 0.22±0.07 | 0.54±0.22 | 37.12±14.86 |
P values among the three groups were less than 0.05.